Company · CIK 1602413
Vyrix Pharmaceuticals, Inc.
| CIK | 1602413 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CO |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-195325 | 2014-04-16 | 2014-11-24 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2014-11-24 | RWWithdrawn | 333-195325 | 0001193125-14-423486 |
| 2014-06-19 | S-1/AAmendment | 333-195325 | 0001193125-14-242421 |
| 2014-06-06 | S-1/AAmendment | 333-195325 | 0001193125-14-228743 |
| 2014-05-07 | S-1/AAmendment | 333-195325 | 0001193125-14-187580 |
| 2014-04-16 | S-1Registration filed | 333-195325 | 0001193125-14-146039 |
| 2014-03-12 | DRSDraft made public | 377-00512 | 0000950123-14-003104 |